[{"id":"58ca73ff-c84e-4c36-8b48-77303f0651d9","acronym":"","url":"https://clinicaltrials.gov/study/NCT01627041","created_at":"2021-01-18T06:59:10.297Z","updated_at":"2024-07-02T16:36:28.861Z","phase":"Phase 2","brief_title":"Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT01627041","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" RARA • CBFB","pipe":"","alterations":" ","tags":["RARA • CBFB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • azacitidine • decitabine • daunorubicin • Starasid (cytarabine ocfosfate)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 178","initiation":"Initiation: 09/16/2011","start_date":" 09/16/2011","primary_txt":" Primary completion: 02/11/2016","primary_completion_date":" 02/11/2016","study_txt":"","study_completion_date":"","last_update_posted":"2021-06-21"},{"id":"d18c9b3e-5c40-4a84-be82-447e5ffdb35d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01050036","created_at":"2021-01-18T04:07:36.364Z","updated_at":"2024-07-02T16:37:08.693Z","phase":"","brief_title":"Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia","source_id_and_acronym":"NCT01050036","lead_sponsor":"Asan Medical Center","biomarkers":" RUNX1 • CBFB","pipe":"","alterations":" ","tags":["RUNX1 • CBFB"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • busulfan"],"overall_status":"Unknown status","enrollment":" Enrollment 39","initiation":"Initiation: 01/01/2010","start_date":" 01/01/2010","primary_txt":" Primary completion: 12/01/2018","primary_completion_date":" 12/01/2018","study_txt":" Completion: 12/01/2018","study_completion_date":" 12/01/2018","last_update_posted":"2018-07-24"}]